申请人:AGENCY SCIENCE TECH & RES
公开号:WO2019054941A1
公开(公告)日:2019-03-21
The application relates to a 2,6-dioxo-purine derivative, 2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(6-(2-hydroxyphenyl)pyridazin-3-yl)acetamide, and the use of this compound in the modulation of the Wnt pathway, and treating a disease or condition associated with Wnt pathway activity, such as cancer, a fibrotic disease, a degenerative disease or a metabolic disease.
该申请涉及一种2,6-二氧嘧啶衍生物,2-(1,3-二甲基-2,6-二氧嘧啶-1,2,3,6-四氢-7H-嘌呤-7-基)-N-(6-(2-羟基苯基)吡啶并[3,4-d]嘧啶-3-基)乙酰胺,并且该化合物在调节Wnt通路和治疗与Wnt通路活性相关的疾病或病况,例如癌症、纤维化疾病、退行性疾病或代谢性疾病方面的应用。